SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-14-268548
Filing Date
2014-07-15
Accepted
2014-07-15 09:00:59
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d754767ds3.htm S-3 182323
2 EX-5.1 d754767dex51.htm EX-5.1 21084
3 EX-5.2 d754767dex52.htm EX-5.2 7531
4 EX-12.1 d754767dex121.htm EX-12.1 22224
5 EX-23.3 d754767dex233.htm EX-23.3 1371
6 EX-23.4 d754767dex234.htm EX-23.4 1718
7 EX-23.5 d754767dex235.htm EX-23.5 3415
8 GRAPHIC g754767g10s01.jpg GRAPHIC 4176
9 GRAPHIC g754767g20k05.jpg GRAPHIC 3306
10 GRAPHIC g754767g46r26.jpg GRAPHIC 2277
11 GRAPHIC g754767g69o06.jpg GRAPHIC 4723
  Complete submission text file 0001193125-14-268548.txt   261162
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-197414 | Film No.: 14974762
SIC: 2834 Pharmaceutical Preparations